Introduction

The diagnosis of these hemoglobinopathies comprises conventional methods and has moved on to molecular diagnosis, depending on the available resources. This session will enable pediatricians, hematologists, gynecologists, and obstetricians to understand the significance of each method, which will further help in devising efficient management plans for such patients.

Introduction

This scientific session is intended to give overview of new class of drugs "Jannus Kinase Inhibitors", as the new emerging drugs in various immune mediated disorders particularly in dermatology.
The session also gives an insight to role of Platelet rich plasma therapy in antiaging and clear our concepts of whitening creams.

Introduction

To examine the emerging data for novel strategies being studied for improving the use and dose titration of guideline-directed medical therapy (GDMT) for heart failure patients. To look at recent trials, including MONITOR-HF and DAPA-HF, in reducing hospitalizations and long-term outpatient department (OPD) and home care management of HFrEF

Introduction

Lung cancer is one of the most common cancers seen worldwide. This session is designed for physicians to get an update on the advances in interventional bronchoscopy, pathology, and management. It should benefit consultants and trainees in general medicine, pulmonology, oncology, primary care, pathology, and other disciplines.

Introduction

Patient engagement can promote mutual accountability and understanding between patients and providers. Patients and caregivers play a central role in health care safety in the hospital, ambulatory care setting, and community. Despite this, interventions to promote patient engagement in safety are still underexplored. There are several promising modes of patient engagement in safety, such as anticoagulation management and patient portal access, but they are not widely implemented. In this era of patient-centered care, health care leaders are in search of efficacious strategies to involve patients and families in health care safety. However, the evidence bases to guide engagement has been limited. In this session, we will discuss major implementation priorities and propose directions for future research and policy to enhance patient partnership within safety efforts.

Introduction

This scientific session is led by the Emergency Services. Resuscitation medicine is a well-respected and established field. Renowned cardiology, nephrology, and critical care experts are involved in this session. This session has an impressive assembly of speakers with years of acute care experience.

Introduction

Nearly 6 million babies are born in Pakistan every year: of these, nearly a million die on the day of their birth. This is a tragedy of massive proportions, not only for the family but also for the nation. A large number of these deaths could be prevented by good antenatal and perinatal care. In particular, if appropriate help is provided during the transitional period when the baby transitions from intrauterine to extrauterine life.

Introduction

Diabetes is a global health problem and carries significant morbidity and mortality. Pakistan ranks third in terms of its diabetic population. Diabetes is a multi-organ disease with a substantial financial and psychological impact on society. Advances in the field of diabetes have improved patient care and helped reduce diabetic complications. Recent clinical trials with new antidiabetic drugs have revolutionized the treatment of diabetes. We aim to discuss recent advances and game-changing innovations in diabetes in this session.

Introduction

As a private, non-profit, non-government trust organization based in Islamabad, Pakistan since 2013, we are dedicated to promoting cutting-edge research and implementation in the field of public health within the domains of non-communicable diseases (NCDs), tobacco control and cessation, and environmental research. Established by a group of passionate public health professionals, The Initiative has been actively engaged in collaborative efforts with the government of Pakistan and esteemed international academic institutions such as the University of York and Edinburgh. Our organization has a strong track record of securing major grants from prominent institutions like the National Institute for Health Research (NIHR), the Medical Research Council (MRC) UK, and the European Union (EU) for implementing and managing large-scale, multi-country research projects. At ICON 2024, we will be showcasing our expertise and contributions within the fields of evidence based research. Our participation in this event is a testament to our commitment to driving positive change and addressing critical health challenges. During the event, we invite you to explore our extensive scientific program. Our team of experienced researchers and professionals will be presenting a wide range of sessions, including policy research insights, Randomized Controlled Trials (RCTs), and impactful publications. These sessions aim to inform and inspire participants, fostering evidence-based policymaking and effective implementation and dissemination strategies. The Session aims at at discussing regarding the on-going projects within the organization (Tobacco Adolescents Program (TAP), Centre for IMPACT, Quit 4 TB Trial and Fresh Air for Life- A collaboration between INDUS hospitals and The Initiative). We will be showcasing our past work of STOP (Studying Tobacco Users Of Pakistan) and our work that has contributed in Policy and Practice. We look forward to connecting with fellow participants, forging new partnerships, and exploring opportunities for collaboration. Together, let's strive towards a healthier and more sustainable future for communities around the world.

Introduction

The session is aimed at equipping the audience with the services of pharmacy in this new era. Pharmacy being an integral part of the healthcare system has a major role beyond just dispensing.
This session helps explore the evolving role of pharmacy services. Delving into innovative approaches, expanding responsibilities and collaborative healthcare initiatives.
Attending this session will help the audience understand the broader impact of pharmacy in healthcare discussing the role of clinical management and turning pharmacists into leaders showcasing the practical insights. The session will also touch upon the cost effectiveness and patient centric approach.

Introduction

Renowned Professor Dr Safdar Ali will be giving the Presentation on the the clinical use of color Doppler sonography in OBGYN. Color Doppler sonography has become an integral part of cardiovascular imaging. Significant improvements have recently occurred, improving the visualization and evaluation of intra-organ vascularity, resulting from enhancements in delineation of tissue detail through electronic compounding and harmonics, as well as enhancements in signal processing of frequency- and/or amplitude-based color Doppler sonography. Spatial representation of vascularity can be improved by utilizing 3D and 4D (live 3D) processing. Greater sensitivity of color Doppler sonography to macro- and microvascular flow has provided improved anatomic and physiologic assessment throughout pregnancy and for pelvic organs. The potential use of contrast enhancement is also mentioned as a means to further differentiate benign from malignant ovarian lesions. The rapid development of these new sonographic techniques will continue to enlarge the scope of clinical applications in a variety of obstetric and gynecologic disorders.

Introduction

A Journey into integrated care for adults and pediatrics at the Indus Hospital Exploring the interconnected world of psychosocial care, highlighting the seamless integration of services tailored to both adults and pediatric patients. Discover how emotional support, mental health care, and resilience-building strategies converge to create a comprehensive healing experience. Gain insights from real-life cases and innovative approaches, inspiring a fresh perspective on patient well-being.

Introduction

The purpose of a scientific session on the theme "Game Changing in Pediatrics" is to gather medical professionals, scientists, and researchers to share their expertise, discuss the latest advances in the field, exchange innovative ideas, and seek solutions to challenges facing children's health.

Introduction

In this talk, we will cover an introduction to recent advances in MASLD. The causing factors are prevalence, when to suspect, how to detect MASLD, and how to manage it.

Introduction

The session aims to highlight recent advances in the approach to managing critically ill and high-risk surgical patients with an emphasis on patient safety and quality of care. The care providers in these environments are working in an environment where complex decisions are made, and interventions carried out in narrow time frames. There is a high risk of errors resulting in adverse outcomes, particularly when dealing with patients with low physiological reserves. The talks in this session highlight the role of anesthesiologist as perioperative physician and custodian of patient safety, proposing ICU quality indicators that are meaningful and measurable in low resource environment, and the value of ultrasound as a tool in point of care decision making in critically ill patients in the ICU and perioperative care setting. Outcome research in anesthesia is largely focused on short term goals focusing on patient comfort and prevention of short-term complications. The focus has recently shifted to measuring the effect of anesthetic interventions on medium- and long-term outcomes. Our panel discussion will explore the outcomes that can guide the doctors, patients and their families in making rational decisions.

Introduction

The impact of air quality in a hospital setting is pivotal for providing an appropriate background for allied and clinical services to run effectively. Key points to consider include: The air quality index is currently a gold standard in various hospital frameworks. It serves as an important indicator of infection control for preventing airborne diseases. Indoor air quality classification in hospitals is crucial. The ASHRAE index and the use of various filtration levels across hospitals are integral to JCI accreditation.

Introduction

Artificial intelligence (AI) is a branch of computer science that deals with the creation of intelligent agents, which are systems that can reason, learn, and act autonomously. AI research has been highly successful in developing effective techniques for solving a wide range of problems, from game-playing to medical diagnosis. AI is being used in healthcare in a variety of ways, including: • Diagnosis: AI can help doctors diagnose diseases by analyzing large amounts of medical data. For example, AI-powered algorithms have been shown to be as accurate as human radiologists at detecting breast cancer in mammograms. • Treatment: AI can be used to develop personalized treatment plans for patients. For example, AI-powered algorithms can predict which patients are most likely to respond to a particular drug treatment. • Surgery: AI-powered robots are being used to perform surgery with greater precision and accuracy than human surgeons. For instance, AI-powered robots have been used to perform complex brain surgeries with a success rate comparable to human surgeons. • Drug discovery: AI can be used to identify new drug targets and design new drugs. For example, AI-powered algorithms have been used to identify new drug targets for Alzheimer's disease. • Healthcare administration: AI can automate administrative tasks in healthcare, such as scheduling appointments and processing claims. For example, AI-powered chatbots can be used to answer patients' questions and provide support